Clinical Trials Logo

Clinical Trial Summary

The clinical study evaluates in an open-label, crossover design the comparative efficacy and safety of intranasal oxytocin and autologous umbilical cord blood for improving the functioning of children with autistic spectrum disorder


Clinical Trial Description

Children aged 3-7 years diagnosed with autistic spectrum disorder and who did not previously receive oxytocin or umbilical cord blood treatments, will be enrolled to receive both treatments in random order. Assessment of functioning impairment will be done with QCHAT/M-CHAT/CAST questionnaires initially, at 2 months, 6 months and 1 year after first treatments. Either oxytocin or cord blood will be administered initially and at visit 2, which will take place at 2 months. All children will receive both treatments. A total of 25-40 children are expected to enroll and complete the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04007224
Study type Interventional
Source Fundatia Bio-Forum
Contact
Status Completed
Phase Phase 1
Start date January 17, 2019
Completion date July 10, 2023

See also
  Status Clinical Trial Phase
Recruiting NCT05497167 - Development and Evaluation of "Period Kits" for Adolescents With Intellectual and Developmental Disabilities N/A
Recruiting NCT05910502 - Project AFECT (Autism Family Empowerment Coaching and Training Program) N/A
Completed NCT06086964 - Effect of Therapeutic Diet With Physiotherapy on Gross Motor and Cognition of Autistic Children N/A
Not yet recruiting NCT05302544 - Impact of Mixed Reality Training on Motor Skills in Children With Autistic Spectrum Disorder N/A
Completed NCT03957044 - the Effect of Vestibular Rehabilitation in Autistic Children N/A
Recruiting NCT05492032 - Cumulative and Booster Effects of Multisession Prefrontal tDCS in Adolescents With ASD N/A
Recruiting NCT06272669 - Cumulative and Booster Effects of Multisession Prefrontal tDCS in Adolescents With ASD N/A
Completed NCT02057809 - "Family-centered" Pediatric Rehabilitation Services in Children With Developmental Disabilities
Completed NCT05077020 - Somatic Diseases in Autistic Children
Completed NCT05025553 - Oral Administration of Polyethylene Glycol (PEG) for 6 Months in Chronically Constipated Autistic Children N/A
Recruiting NCT04243382 - Treatment of Children With Autistic Spectrum Disorder With Autologous Umbilical Cord Blood, a Pilot Study Phase 2
Completed NCT04261595 - Dates as a Functional Food for Autism N/A
Completed NCT05515913 - Nutritional Status and ASD Severity of Autistic Spectrum Disorder Children in Addis Ababa, Ethiopia; Case Control Study
Completed NCT05875363 - Neurodevelopmental Disorders in Youth With Criminal Behaviors